Hot Heal Care Companies To Invest In 2015

Although we don't believe in timing the market or panicking over market movements, we do like to keep an eye on big changes -- just in case they're material to our investing thesis.

What: Shares of giant tire manufacturer Titan International (NYSE: TWI  ) fell 13% today after being downgraded by analysts.

So what: Jefferies downgraded the stock from buy to hold, citing the probability of profit and sales pressure. William Blair also downgraded the stock to market perform and lowered its price target to $21. �

Now what: At The Motley Fool,�we don't take analyst upgrades or downgrades very seriously because they just don't have much incentive to get ratings right. What we do know is that shares currently trade at 12 times trailing earnings, which isn't a bad value if revenue is at least flat. But the price of raw materials miners around the world are producing have been down and it wouldn't be surprising to see a decline in revenue. The spending spree in mining may be over and that would be a good reason to sell the stock today, not just the downgrade of two analysts.

Interested in more info on Titan International? Add it to your Watchlist by clicking here.

Hot Heal Care Companies To Invest In 2015: UniPixel Inc (UNXL)

Uni-Pixel, Inc. (Uni-Pixel), incorporated on October 13, 2000, is a production-stage company delivering its Performance Engineered Film (PEF) to the display, touch screen and flexible electronics markets. The Company has developed thin film high volume roll to roll or continuous flow manufacturing process. The Company sells its films as sub-components for use in liquid crystal display (LCD) as a back light film and active film sub-component. Uni-Pixel is shipping its Diamond Guard Finger Print Resistant and Hard Coat (Anti-Scratch) protective cover films for multiple touch enabled devices. The Company sells its films under the Diamond Guard brand as well as private label to original equipment manufacturers (OEMs). It is making ITO-Less Touch Films and Flexible Electronic Films based on its UniBoss manufacturing process for high volume roll to roll printing of flexible thin-film conductor patterns.

The Company�� Diamond Guard FPR product can protect a touch screen device from damage while also preventing fingerprints and smudges from obscuring the viewing experience. Its Diamond Guard Anti-Scratch protective cover film product is used to protect touch screen devices from scratches while providing a transparency and gloss equivalent to glass. In other embodiments, the Company's Diamond Guard coating can be applied to substrates that can be used as the first surface of hand held electronic devices. The Company developed a color display technology called Time Multiplexed Optical Shutter (TMOS).

Advisors' Opinion:

• [By Roberto Pedone]

  Another stock that looks poised for a major breakout trade is Uni-Pixel (UNXL), which manufactures electronic film products using its proprietary manufacturing process, UniBoss, and delivers its products to the display, touch screen and flexible electronics market segments. This stock is off to a decent start so far in 2013, with shares up 23%.

  If you take a look at the chart for Uni-Pixel, you'll notice that this stock has been uptrending for the last two months, with shares moving higher from its low of $11.39 to its recent high of $18.33 a share. During that uptrend, shares of UNXL have been making mostly higher lows and higher highs, which is bullish technical price action. Shares of UNXL recently pulled right back to its 50-day moving average at $14.91 a share, and the stock has now started to bounce strongly off that level and move within range of triggering a major breakout trade.

  Traders should now look for long-biased trades in UNXL if it manages to break out above some near-term overhead resistance levels at $18.33 to $18.67 a share and then once it clears its 200-day moving average at $19.07 a share with high volume. Look for a sustained move or close above those levels with volume that hits near or above its three-month average action 1.27 million shares. If that breakout triggers soon, then UNXL will set up to re-test or possibly take out its next major overhead resistance levels $25 to $30 a share.

  Traders can look to buy UNXL off any weakness to anticipate that breakout and simply use a stop that sits right below its 50-day at $14.91 a share. One could also buy UNXL off strength once it takes out those breakout levels with volume and then simply use a stop that sits a comfortable percentage from your entry point.

Hot Heal Care Companies To Invest In 2015: Computer Sciences Corporation(CSC)

Computer Sciences Corporation provides information technology (IT) and professional services to governments and commercial enterprises. The company?s IT outsourcing services comprise operating customer?s technology infrastructure, including systems analysis, applications development, network operations, desktop computing, and data center management services; business process outsourcing; managing transactional business functions for clients, such as procurement and supply chain, call centers and customer relationship management, credit services, claims processing and logistics. It also offers cloud computing and cyber security protection services. In addition, the company provides range of services in the areas of infrastructure as a service, software as a service (SaaS), business process as a service, platform as a service, and other technologies. Further, its IT and professional services consist of systems integration, including designing, developing, implementing, and i ntegrating information systems; and management consulting, technology consulting, and other professional services, consist of advising clients on the strategic acquisition and utilization of IT and on business strategy, security, modeling, simulation, engineering, operations, change management, and business process reengineering. Additionally, the company licenses software systems, including SaaS offerings for the financial services and other industry-specific markets; and provides a range of end-to-end business solutions. It has its operations primarily in North America, Europe, Asia, and Australia. The company was founded in 1959 and is based in Falls Church, Virginia.

Advisors' Opinion:

• [By Tom Taulli]

  Innovation: Innovation is a major priority at AT&T. And so far, it looks like the company is making savvy moves, particularly with its push into the cloud. To this end, AT&T has rolled out NetBond, which involves alliances with top providers like IBM (IBM), Microsoft (MSFT), CSC (CSC) and Equinix (EQIX). But perhaps the most interesting growth initiative is Digital Life, which allows customers to use their smartphones as remote control devices with homes and cars. All in all, the opportunity could be huge, adding another nice revenue stream — AT&T already has agreements with companies like GM (GM), Ford (F), Nissan, Audi, BMW and Tesla (TSLA)

• [By CRWE]

  CSC (NYSE:CSC) reported that it has signed a contract with the Health and Social Care Information Centre (HSCIC) to deliver SystmOne data extracts as part of the General Practice Extraction Service (GPES).

• [By Reuters]

  Carlos Osorio/APFord CEO Alan Mulally NEW YORK -- Microsoft has narrowed its list of external candidates to replace Chief Executive Officer Steve Ballmer to about five people, including Ford Motor chief Alan Mulally and former Nokia CEO Stephen Elop, according to sources familiar with the matter. The world's largest software maker also has at least three internal candidates on its shortlist, including former Skype CEO Tony Bates, who is now responsible for Microsoft's business development, and Satya Nadella, the company's cloud and enterprise chief, the sources said. Despite the narrower list -- the company started with about 40 names -- the process could take a few more months, the sources said. In August, Ballmer said he would retire within 12 months. The names of other candidates couldn't be learned, but the search committee is interviewing executives from a wide range of sectors, including life sciences and consumer, the sources said. Microsoft (MSFT) declined to comment on the process and on behalf of the internal candidates. A Nokia (NOK) representatives couldn't be reached immediately for comment late Tuesday. Ford (F) spokesman Jay Cooney said: "There is no change from what we announced last November. Alan remains fully focused on continuing to make progress on our One Ford plan. We do not engage in speculation." Investors have pushed Microsoft's board in recent months to look for a turnaround expert, such as Mulally or Computer Sciences (CSC) CEO Mike Lawrie, to succeed Ballmer. Some investors have also suggested to the board that co-founder Bill Gates should step down from his role as chairman, saying he stands in the way of radical reform at Microsoft. Microsoft remains highly profitable and last month beat Wall Street's quarterly profit and revenue forecasts. But it has lost ground to Apple (AAPL) and Google (GOOG) in mobile computing. Ballmer has focused on making devices, such as the Surface tablet and Xbox gaming console, and turning k

• [By Jon C. Ogg]

  Computer Sciences Corp. (NYSE: CSC) posted a rise in earnings, aided by lower costs and improved margins from a year ago. Its stock has recovered handily from the turnaround days, and shares were up almost 6% in the evening trading session on Tuesday, and they are indicated higher on Wednesday as well.

Top 5 Undervalued Stocks For 2015: Zweig Fund Inc (ZF)

The Zweig Fund, Inc. (the Fund), incorporated on June 30, 1986, is a closed-end, diversified management investment company. The Fund�� objective is to increase capital primarily with investment in equity securities, consistent with capital preservation and reduction of risk. The Fund�� principal stock market sectors as on June 30, 2007, included information technology, financials, industrials, energy and healthcare.

The Fund�� investment adviser is Phoenix/Zweig Advisers LLC. As of June 30, 2007, its principal industrial positions included Cisco Systems, Corning Inc., EMC Corp., Ford, Goldman Sachs, Morgan Stanley, PowerShares QQQ, Nike, Nokia Corp. and Valero Energy.

Advisors' Opinion:

• [By Nathan Slaughter]

  Consider the Zweig Fund (NYSE: ZF). It's a closed-end fund that has $340 million in net assets, which are invested in a diverse basket of blue-chip stocks such as PepsiCo, Apple, JPMorgan, Comcast, U.S. Bancorp and Qualcomm.

Hot Heal Care Companies To Invest In 2015: Korn/Ferry International (KFY)

Korn/Ferry International, together with its subsidiaries, provides talent management solutions that help clients to design strategies in building and attracting their talent. It operates in three segments: Executive Recruitment, Leadership & Talent Consulting (LTC), and High-Impact Recruitment Solutions. The Executive Recruitment segment focuses on recruiting board-level, chief executive, and other senior executive positions primarily in the consumer, financial services, and industrial, as well as in life sciences/healthcare, and technology industries. The LTC segment provides leadership and talent management solutions to assist clients with their ongoing assessment, organizational design, and leadership development efforts. The High-Impact Recruitment Solutions segment engages in enterprise-wide consulting and recruitment solutions, including recruitment process outsourcing, talent acquisition and management consulting services, project-based recruitment, mid-level recrui tment, and interim professionals. The company serves public and private companies, middle market and emerging growth companies, government agencies, and nonprofit organizations in North America, Europe, the Middle East, Africa, the Asia Pacific, and South America. Korn/Ferry International was founded in 1969 and is headquartered in Los Angeles, California.

Advisors' Opinion:

• [By Anna Prior]

  Korn/Ferry International's(KFY) fiscal second-quarter profit surged due in large part to a big revenue boost in the company’s leadership and talent consulting business, as well as a favorable comparison to the year-ago period. Shares rose 5.3% to $23.70 premarket as the company’s earnings beat its expectations.

Hot Heal Care Companies To Invest In 2015: Pervasive Software Inc.(PVSW)

Pervasive Software, Inc. provides embeddable software and SaaS services for data management, data integration, B2B exchange, and analytics. Its embeddable Pervasive PSQL database engine provides database reliability in a near-zero database administration environment for packaged business applications. Pervasive Software?s multi-purpose data integration platform, available on-premises and in the cloud, accelerates the sharing of information between multiple data stores, applications, and hosted business systems, and allows customers to re-use the same software for diverse integration scenarios. Pervasive DataRush is an embeddable parallel-processing platform enabling data-intensive applications, such as claims processing, risk analysis, fraud detection, data mining, predictive analytics, sales optimization, and marketing analytics. The company serves customers in approximately 150 countries. Pervasive Software, through Pervasive Innovation Labs, also invests in the explorat ion and creation of solutions for the data analysis and data delivery challenges. Pervasive Software, Inc. has a strategic alliance with A.D.A.M. Inc. The company was founded in 1994 and is headquartered in Austin, Texas with additional offices in Greenville, South Carolina; Brussels, Belgium; Frankfurt, Germany; Paris, France; and London, the United Kingdom.

Advisors' Opinion:

• [By CRWE]

  Pervasive Software(R) Inc. (NASDAQ:PVSW), a global leader in cloud-based and on-premises data innovation, reported that it is in receipt of an unsolicited non-binding letter from Actian Corporation proposing to acquire all of the outstanding shares of Pervasive common stock for $8.50 per share in cash.

Hot Heal Care Companies To Invest In 2015: Raven Industries Inc.(RAVN)

Raven Industries, Inc., together with its subsidiaries, manufactures various products for industrial, agricultural, energy, construction, and military/aerospace markets primarily in North America. It operates in four segments: Applied Technology, Engineered Films, Aerostar, and Electronic Systems. The Applied Technology segment designs, manufactures, sells, and services precision agriculture products and information management tools enabling growers to enhance farm yields. Its products include field computers, application controls, GPS-guidance and assisted-steering systems, automatic boom controls, and yield monitoring planter controls, as well as an integrated real time kinematic and information platform called Slingshot. This segment sells its products to original equipment manufacturers, as well as through after market distributors. The Engineered Films segment produces rugged reinforced plastic sheeting for industrial, construction, geomembrane, and agricultural appli cations. It sells plastic sheeting to independent third-party distributors through its sales force. The Aerostar segment sells high-altitude research balloons and tethered aerostats for government and commercial research. It produces military parachutes, uniforms, and protective wear for the U.S. government agencies as a subcontractor; and other sewn and sealed products on a contract basis. The Electronic Systems segment provides electronics manufacturing services for commercial customers. It manufactures assemblies, including avionics, communication, environmental controls, and other products. The company was founded in 1956 and is headquartered in Sioux Falls, South Dakota.

Advisors' Opinion:

• [By Dividends4Life]

  Memberships and Peers: MMM is a member of the S&P 500, a Dividend Aristocrat, a member of the Broad Dividend Achievers��Index and a Dividend Champion. The company's peer group includes: General Electric Co. (GE) with a 3.1% yield, Raven Industries Inc. (RAVN) with a 1.6% yield and Carlisle Companies Inc. (CSL) with a 1.2% yield.

Hot Heal Care Companies To Invest In 2015: Salesforce.com Inc (CRM)

Salesforce.com, inc., incorporated in February 1999, is a provider of enterprise cloud computing and social enterprise solutions. The Company provides a customer and collaboration relationship management (CRM), applications through the Internet or cloud. Cloud computing refers to the use of Internet-based computing, storage and connectivity technology to deliver a variety of different services. The Company delivers its service through Internet browsers and mobile devices. It markets its social enterprise applications and platforms to businesses on a subscription basis, primarily through its direct sales efforts and indirectly through partners. In January 2011, it acquired Heroku, Inc. and DimDim, Inc. In May 2011, the Company acquired Radian6 Technologies Inc. In September 2011, the Company acquired Assistly. In August 2012, the Company acquired Buddy Media. In May 2013, SalesForce.com Inc acquired Clipboard Inc.

The Company introduced Chatter, a collaboration application for the enterprise to connect and share information securely and in real-time. It serves its customers from third-party data center hosting facilities located in the United States and other countries. The Company�� primary applications are sales cloud, service cloud, salesforce chatter, Salesforce Radian6 and Salesforce Data.com.

The Company�� customers are able to establish a system and process for recording, tracking, and sharing information about sales opportunities, sales leads, sales forecasts, the sales process, and closed business, as well as managing sales territories. Customers are able to create social profiles of their customers, based on information from social networking services like Facebook, Twitter and LinkedIn. Its customers are also able to manage unstructured information, such as sales collateral, presentations, price lists, and video assets. In addition, the Sales Cloud encompasses partner relationship management functionality (including channel management and partner portals) and m! arketing automation (including campaigns, and return-on-investment tracking).

The Company�� customer service and support automation features are marketed under its Service Cloud brand and allow its customers to service and engage with their customers. Using the Service Cloud, companies can access a solution for their customer service interactions across every service channel: call centers with phone, email, and chat; Web portals for self-service and customer collaboration; and community interactions within social networks. In addition, built-in collaboration tools enable customer service agents to share information on how to better service customers.

The Company�� Chatter application enables customers to create private employee social networks for companies of all sizes in order to improve employee collaboration. For customers of its Sales and Service Cloud editions, Chatter is included free for all subscribers. In addition, it offers Chatter Plus edition, designed to provide access to Chatter for employees in customers��organizations who are not subscribers of a Sales or Service Cloud edition. It delivered features, including Chatter Now for real-time collaboration, and Chatter Customer Groups enabling users to invite people outside their organizations, such as customers and partners, into their Chatter network to collaborate in a secure environment. Chatter is a core attribute of its Force.com platform and its social capabilities are an integral part of each of its application offerings and its Social Enterprise solution.

The Company�� Radian6 application provides its customers a tool for social media monitoring and marketing. The application allows companies to listen, analyze, engage and measure their brand�� presence within social media. It provides companies with a database of business contacts, company profiles and social insights. Delivered as a service, data.com integrates with its applications to provide the business data that helps companies in! crease th! eir pipeline of sales leads.

The Company�� cloud platforms provide application developers access to new capabilities that can be built into their business applications. These platforms include features popularized by social networking companies, such as profiles, status updates and feeds, and also the capability to extend applications for use on mobile devices. In addition, they run on its Database.com offering, an open enterprise database built for social and mobile computing. Its cloud platforms allow both information technology (IT) departments and independent software vendors (ISV) developers to use several programming languages to build their applications. Developers are able to use the programming languages on its cloud platforms, such as Java and Ruby, to build their applications, and its cloud platforms support multiple other languages to provide developers openness and choice.

The Company has two platform offerings: Force.com and Heroku, and offer additional developer tools, such as Database.com and the AppExchange. The Force.com cloud computing platform provides a feature set and technology environment for building business applications, including data models and objects to manage data, a workflow engine for managing collaboration of data between users, a user interface model to handle forms and other interactions, and a Web services API for programmatic access and integration. Heroku is a cloud platform for application developers to build and deploy social and mobile applications. Built on open standards, Heroku supports multiple frameworks, databases, and languages, including Java and Ruby. The AppExchange is an online directory that provides customers a way to browse, sample, share, and install applications developed on its Force.com platform. Partners and developers can offer their applications and services for a fee on the AppExchange directory. This directory gives its users a way to find and install applications to expand their use of the Force.com platform t! o areas t! hat are complementary to its social enterprise solution.

The Company offer consulting, deployment and training services to our customers to facilitate the adoption of its social enterprise services. Consulting services consist of services, such as business process mapping, project management services and guidance on best practices in using its service. Deployment services include systems integration, technical architecture and development, configuration and data conversion, as well as developing and delivering customized education programs for its customers. Most of its consulting and deployment engagements are billed on a time and materials basis. It offer a number of traditional classroom and online educational classes that address topics, such as deploying, using, administering and developing on its service. It also offers classes for its partners who deploy its service on behalf of its customers.

Advisors' Opinion:

• [By Chris Hill]

  Dollar General's (NYSE: DG  ) first-quarter profits rose rose 3%, but the retailer cut guidance for the full year. Business market software maker ExactTarget (NYSE: ET  ) rose more than 50% after Salesforce.com (NYSE: CRM  ) agreed to buy the company for more than $2.3 billion. Zynga (NASDAQ: ZNGA  ) held firm after shares tanked on Monday in the wake of the company announcing it's cutting 18% of its staff. And IBM (NYSE: IBM  ) buys a company to better compete in the cloud computing space. In this installment of Investor Beat, our analysts discuss four stocks making big moves.

Hot Heal Care Companies To Invest In 2015: Chesapeake Lodging Trust (CHSP)

Chesapeake Lodging Trust (the Trust) is a self-advised real estate investment trust (REIT). The Trust is focused on investments primarily in upper-upscale hotels in business and convention markets and, on a selective basis, select-service and extended-stay hotels in urban settings or locations in the United States of America. All of the Trust�� assets are held by, and all of its operations are conducted through, Chesapeake Lodging, L.P., its operating partnership (the Operating Partnership). The Operating Partnership leases its hotels to CHSP TRS LLC (CHSP TRS), which is a wholly owned subsidiary of the Operating Partnership. CHSP TRS engages hotel management companies to operate the hotels pursuant to management agreements. CHSP TRS is a taxable REIT subsidiary (TRS). As of December 31, 2011, the Trust owned 12 hotels with an aggregate of 3,516 rooms in six states and the District of Columbia. In August 2012, the Company acquired the 520-room W Chicago-Lakeshore located in Chicago, Illinois from Starwood Hotels & Resorts Worldwide Inc. (Starwood). The Trust entered into a long-term management agreement with Starwood to continue operating the hotel under the W flag. In September 2012, it acquired the 429-room Hyatt Regency Mission Bay Spa and Marina, located in San Diego, California. In October 2012, the Company acquired 222-room The Hotel Minneapolis, a Marriott Autograph Collection hotel, located in Minneapolis. In March 2013, the Company acquired 185-room Hyatt Place New York Midtown South, located in New York. In April 2013, Starwood Hotels & Resorts Worldwide Inc completed the sale of W New Orleans - French Quarter to Chesapeake Lodging Trust. In April 2013, Chesapeake Lodging Trust acquires W New Orleans From Starwood Hotels & Resorts Worldwide Inc. In June 2013, Chesapeake Lodging Trust purchased the Hyatt Fisherman's Wharf from Hyatt Hotels Corp. Effective June 27, 2013, Chesapeake Lodging Trust acquired Hyatt Santa Barbara.

On December 22, 2011, the Trust acquired Holiday Inn ! New York City Midtown, which had 122 rooms. On October 3, 2011, the Trust acquired Denver Marriott City Center hotel, which had 613 rooms. On July 8, 2011, it acquired Hotel Adagio, which consisted of 171 rooms. On June 30, 2011, the Trust acquired Courtyard Washington Capitol Hill/Navy Yard hotel, which had 204 rooms. On June 17, 2011, it acquired Hotel Indigo San Diego Gaslamp Quarter, which consisted of 210 rooms. On May 10, 2011, the Trust acquired W Chicago - City Center hotel, which had 368 rooms. On May 2, 2011, it acquired Homewood Suites Seattle Convention Center hotel, which had 195 rooms.

The Company has management agreements with third parties to manage its hotels. The Trust's hotel managers provide managerial and other hotel employees, oversee operations and maintenance, prepare reports, budgets and projections and provide other administrative and accounting support services. Its management agreements provide for base management fees ranging from 1% to 4% of gross hotel revenues and incentive compensation if hotel operating income. Of its 12 hotels, seven operates pursuant to franchise agreements from international hotel companies. The Trust�� lease agreements are inter-company agreements between its property-owning subsidiaries and its TRS lessees.

Advisors' Opinion:

• [By Rich Duprey]

  Real estate investment trust�Chesapeake Lodging Trust� (NYSE: CHSP  ) �announced yesterday its second-quarter dividend of $0.24 per share, the same rate it paid last quarter after raising the payout 9% from $0.22 per share.

Hot Heal Care Companies To Invest In 2015: Harris & Harris Group Inc.(TINY)

Harris & Harris Group, Inc. is a venture capital and venture debt firm specializing in seed, start up, early stage, and mid venture investments. It primarily invests in tiny-technology-enabled companies with a focus on nanotechnology, microsystems, and microelectromechanical systems technology. Harris & Harris Group, Inc. was founded in 1981 and is based in New York, New York with additional offices in Palo Alto, California and Los Angeles, California.

Advisors' Opinion:

• [By Sally Jones]

  Highlight: Harris & Harris Group Inc. (TINY)

  The TINY share price is currently $3.07 or 22.1% off the 52-week high of $3.94. The company does not pay a dividend.

Hot Heal Care Companies To Invest In 2015: Two Harbors Investment Corp (TWO)

Two Harbors Investment Corp. (Two Harbors), incorporated on May 21, 2009, operates as a real estate investment trust (REIT). The Company is focused on investing in, financing and managing residential mortgage-backed securities (RMBS), residential mortgage loans, residential real properties, and other financial assets. The Company focuses on security selection and implements a relative value investment approach across various sectors within the residential mortgage market. Its target assets include Agency RMBS, Non-Agency RMBS, residential mortgage loans, residential real properties and other financial assets comprising approximately 5% to 10% of the portfolio. The Company has designated certain of its subsidiaries as taxable REIT subsidiaries (TRSs). Capitol Acquisition Corp. (Capitol) is a wholly owned indirect subsidiary of Two Harbors. The Company is externally managed and advised by PRCM Advisers LLC, a wholly owned subsidiary of Pine River Capital Management L.P. (Pine River).

The Company invests primarily in mortgage pass-through certificates, collateralized mortgage obligations and other residential mortgage-backed securities representing interests in or obligations backed by pools of mortgage loans issued by Federal National Mortgage Association (Fannie Mae), Federal Home Loan Mortgage Corporation (Freddie Mac), and Government National Mortgage Association (GNMA) (collectively GSEs). The Company also invests in residential mortgage-backed securities that are not issued by the GSEs (non-Agency RMBS) and United States Treasuries. At December 31, 2011, the Company had total assets of approximately $8.1 billion, of which $6.2 billion, or 77.1%, represented its RMBS portfolio. At December 31, 2011, $5.1 billion, or 80.9%, of its RMBS portfolio was comprised of Agency RMBS, $0.9 billion, or 14.9%, of its RMBS portfolio was comprised of senior non-Agency RMBS, and the remaining $0.2 billion, or 4.2%, was comprised of other non-Agency RMBS. The remaining $1.9 billion of assets consisted p! rimarily of United States Treasuries classified as trading instruments, cash, restricted cash, mortgage loans held-for-sale, receivables, derivative assets and prepaid assets.

Advisors' Opinion:

• [By Rich Duprey]

  Mortgage-backed securities REIT�Two Harbors Investment (NYSE: TWO  ) announced today its second-quarter dividend of $0.31�per share, $0.01 per share lower than it paid last quarter.

• [By Doug Fabian]

  This fund is pegged to the FTSE NAREIT All Mortgage Capped Index, a benchmark measure that includes top names in the space such as Annaly Capital (NLY), American Capital Agency Corp. (AGNC), Starwood Property Trust (STWD) and Two Harbors Investment Corp. (TWO).

Hot Heal Care Companies To Invest In 2015: Synergy Resources Corp (SYRG)

Synergy Resources Corporation, incorporated on May 11, 2005, is an oil and gas operator in Colorado. The Company is focused on the acquisition, development, exploitation, exploration and production of oil and natural gas properties primarily located in the Denver-Julesburg Basin (D-J Basin) in northeast Colorado. Effective November 13, 2013, Synergy Resources Corp acquired 21 undisclosed oil and gas producing wells, located in Wattenberg Field, Colorado.

As of October 31, 2013, the Company has 374,000 gross and 245,000 net acres under lease, substantially all of which are located in the D-J Basin. Of this acreage, 12,550 gross acres are held by production. In addition to the approximately 22,000 net developed and undeveloped acres that the Company hold in the Wattenberg Field, it hold undeveloped acreage positions in the northern extension area of the D-J Basin, in an area around Yuma County that produces dry gas, and in western Nebraska.

Advisors' Opinion:

• [By Value Digger]

  As peers, I selected Artek Exploration (ARKXF.PK), RMP Energy (OEXFF.PK), Synergy Resources (SYRG) and Magnum Hunter Resources (MHR). The first two firms trade also on the main Toronto board under the tickers RTK.TO and RMP.TO respectively. These peers comply with the following criteria:

Hot Heal Care Companies To Invest In 2015: Inovio Pharmaceuticals Inc (INO)

Inovio Pharmaceuticals, Inc., incorporated on June 29, 1983, is engaged in the development of a new generation of vaccines, called synthetic vaccines, focused on cancers and infectious diseases. The Company's SynCon technology enables the design of universal vaccines capable of providing cross-protection against existing or changing strains of pathogens, such as influenza and human immunodeficiency virus (HIV). The Company's electroporation delivery technology uses brief, controlled electrical pulses to increase cellular uptake of the vaccine. Its clinical programs include cervical dysplasia (therapeutic), avian influenza (preventive), prostate cancer (therapeutic), leukemia (therapeutic), hepatitis C virus (HCV) and HIV vaccines. It is advancing preclinical research and clinical development for a universal seasonal/pandemic influenza vaccine, as well as preclinical work for other products, including malaria and prostate cancer vaccines. Its partners and collaborators include University of Pennsylvania, Drexel University, National Microbiology Laboratory of the Public Health Agency of Canada, Program for Appropriate Technology in Health/Malaria Vaccine Initiative (PATH/MVI), National Institute of Allergy and Infectious Diseases (NIAID), Merck, ChronTech, University of Southampton, United States Military HIV Research Program (USMHRP), the United States Army Medical Research Institute of Infectious Diseases (USAMRIID) and HIV Vaccines Trial Network (HVTN). As of December 31, 2011 it owned 16.1% interest in VGX Int��.

Inovio�� Solution

The Company�� synthetic vaccine platform consists of its SynCon vaccine design process and electroporation delivery technology. It has developed a preclinical and clinical stage pipeline of vaccines. The Company�� synthetic vaccines are designed to prevent a disease (prophylactic vaccines) or treat an existing disease (therapeutic vaccines). Its synthetic vaccine consists of a deoxyribonucleic acid (DNA) plasmid encoding a selected antigen! (s), which is introduced into cells of humans or animals with the purpose of evoking an immune response to the encoded antigen. The Company�� synthetic vaccines are designed to generate specific antibody and/or T-cell responses.

The Company�� SynCon technology provides processes that employ bioinformatics, which combine extensive genetic data and sophisticated algorithms. Its design process uses the genetic make-up of a common antigen(s) from multiple strains of a virus within a viral sub-type or taxonomic group (family) of pathogens, such as HIV, hepatitis C virus (HCV), human papillomavirus (HPV), influenza and other diseases to synthetically create a new antigen for the desired pathogen target that does not exist in nature. Its synthetic vaccine candidates are being delivered into cells of the body using its electroporation (EP) DNA delivery technology.

Cancer Synthetic Vaccines

The Company has two broad types of cancer vaccines: preventive (or prophylactic) vaccines, which are intended to prevent cancer from developing in healthy people, and treatment (or therapeutic) vaccines, which are intended to treat an existing cancer by strengthening the body�� natural defenses against the cancer. Two types of cancer preventive vaccines are available in the United States. The United States Food and Drug Administration (the FDA) has approved two vaccines, Gardasil and Cervarix that protect against infection by the two types of HPV-types 16 and 18-that cause approximately 70% of all cases of cervical cancer worldwide. In addition, Gardasil protects against infection by two additional HPV types, 6 and 11, which are responsible for about 90% of all cases of genital warts in males and females but do not cause cervical cancer.

Cervarix manufactured by GlaxoSmithKline, is composed of virus-like particles (VLPs) made with proteins from HPV types 16 and 18. Cervarix is approved for use in females��ages 10 to 25 for the prevention of cervical cancer caused by! HPV type! s 16 and 18. Gardasil manufactured by Merck, is approved for use in females for the prevention of cervical cancer, and some vulvar and vaginal cancers, caused by HPV types 16 and 18 and for use in males and females for the prevention of genital warts caused by HPV types 6 and 11. The vaccine is approved for these uses in females and males ages 9 to 26. The FDA has also approved a cancer preventive vaccine that protects against hepatitis B virus (HBV) infection.

Inovio�� VGX-3100 is designed to raise immune responses against the E6 and E7 genes of HPV types 16 and 18 that are present in both pre-cancerous and cancerous cells transformed by these HPV types. E6 and E7 are oncogenes that play an integral role in transforming HPV-infected cells into cancerous cells. In March 2011, it initiated a randomized, double-blind Phase II study of VGX-3100 delivered using the CELLECTRA intramuscular electroporation device in women with HPV Type 16 or 18 and diagnosed with, but not yet treated for, cervical intraepithelial neoplasia (CIN) 2/3. The study is designed to enroll 148 subjects. In January 2011, it announced the publication of a scientific paper in the journal Human Vaccines detailing potent immune responses in a preclinical study of its SynCon vaccine for prostate cancer targeting two antigens, prostate specific antigen (PSA) and prostate specific membrane antigen (PSMA).

In January 2011, the Company announced the regulatory approval of a Phase II clinical trial (WIN Trial) to treat leukemia utilizing its new ELGEN 1000 automated vaccine delivery device. The single dose level, Phase II study, called WT1 immunity via DNA fusion gene vaccination in haematological malignancies by intramuscular injection followed by intramuscular electroporation. Cancer Vaccines encodes for hTERT, an antigen related to non-small cell lung, breast and prostate cancers. The vaccine is delivered using its electroporation delivery technology.

Infectious Disease Synthetic Vaccines

In Marc! h 2011, the Company announced the initiation of a follow-on open label, single dose Phase II clinical study in collaboration with ChronTech of the ChronVac-C HCV DNA vaccine delivered using its electroporation technology in treatment naive HCV infected individuals. Its HIV vaccines consist of candidates for HIV prevention, as well as therapy or treatment. PENNVAX-B is designed to target HIV clade B (most commonly found in the United States, North America, Australia and the European Union (EU). PENNVAX-G is designed to target HIV clades A, C and D, which are more commonly found in Asia, Africa, Russia and South America. This Phase I clinical study of PENNVAX-B (HVTN-080) vaccinated 48 healthy, HIV-negative volunteers to assess safety and levels of immune responses generated by Inovio�� PENNVAX-B vaccine delivered with its CELLECTRA electroporation device. PENNVAX-B is a SynCon vaccine that targets HIV gag, pol, and env proteins.

The Company�� VGX-3400X targets H5N1. The vaccine consists of three distinct DNA plasmids coded for a consensus hemagglutinin (HA) antigen derived from different H5N1 virus strains; a consensus neuraminidase (NA) antigen derived from different N1 sequences; and a consensus nucleoprotein (NP) fused to a small portion of the m2 protein (m2E) based on a broader cross-section of influenza viruses in addition to H5N1 and H1N1. Conventional vaccines are strain-specific and have limited ability to protect against genetic shifts in the influenza strains they target. They are therefore modified annually in anticipation of the next flu season�� new strain(s). It is focused on developing DNA-based influenza vaccines able to provide broad protection against known as well as newly emerging, unknown seasonal and pandemic influenza strains.

Animal Health/Veterinary

VGX Animal Health, Inc. (VGX AH), a majority-owned subsidiary, has licensed LifeTide, a plasmid-based growth hormone releasing hormone (GHRH) technology for swine. LifeTide is one of onl! y four DN! A-based treatments approved for use in animals and is the only DNA-based agent delivered using electroporation that has been granted marketing approval (Australia). VGX AH is also developing a GHRH-based treatment for cancer and anemia in dogs and cats. It is developing a synthetic vaccine for foot-and-mouth disease (FMD) administered by its vaccine delivery technology. The FMD virus is one of the most infectious diseases affecting farm animals, including cattle, swine, sheep and goats, and is a serious threat to global food safety.

The Company competes with Crucell N.V, Sanofi-Aventis, Novartis, Inc., GlaxoSmithKline plc, Merck, Pfizer, AstraZeneca, Inc., Novartis, Inc., MedImmune and CSL.

Advisors' Opinion:

• [By Jake L'Ecuyer]

  Equities Trading DOWN
  Shares of Inovio Pharmaceuticals (NYSE: INO) were down on Friday's session, falling 13.28 percent to $2.488 despite seemingly little news on the company.

• [By Sean Williams]

  On the clinical data front, Alnylam Pharmaceuticals (NASDAQ: ALNY  ) and Inovio Pharmaceuticals (NYSEMKT: INO  ) both put investors in their happy place.

Hot Heal Care Companies To Invest In 2015: Halozyme Therapeutics Inc.(HALO)

Halozyme Therapeutics, Inc., a biopharmaceutical company, engages in the research, development, and commercialization of recombinant human enzymes that transiently modify tissue under the skin to facilitate injection of other therapies or correct diseased tissue structures for clinical benefits. The company primarily offers recombinant human hyaluronidase, an enzyme that degrades hyaluronan, which is a matrix component in the skin, and facilitates the dispersion and absorption of drugs and fluids. Its portfolio of products and product candidates are developed based principally on intellectual property covering the family of human enzymes known as hyaluronidases. The company also provides Ultrafast Insulin program, a Phase II clinical trial product for the treatment of diabetes mellitus; and Enhanze technology, a proprietary drug delivery platform for subcutaneous delivery of injectable biologics, such as monoclonal antibodies and other therapeutic molecules, as well as sma ll molecules and fluids. It offers PEGPH20, a new molecular entity that is in Phase I trial for the systemic treatment of tumors; and HTI-501, a recombinant human proteinase, which is in Phase 1/2 clinical trial used for the treatment of edematous fibrosclerotic panniculopathy (cellulite). The company has collaborative partnerships with F. Hoffmann-La Roche, Ltd and Hoffmann-La Roche, Inc.; ViroPharma Incorporated; and Intrexon Corporation to apply Enhanze technology to the partners? biological therapeutic compounds. Halozyme Therapeutics, Inc. was founded in 1998 and is based in San Diego, California.

Advisors' Opinion:

• [By John Udovich]
  Follow-on Stock Offerings From Small Cap Biotech Stocks. Thanks to the boom in biotech IPOs along with the sector�� overall performance, already listed biotechs have the option to ask investors for more cash in the form of a follow-on offering. Recently, FierceBiotech.com noted how four small cap biotechs raised $276 million from follow-on offerings in just one day last week. These small caps�included Epizyme Inc (NASDAQ: EPZM) which raised $88 million, Halozyme Therapeutics, Inc (NASDAQ: HALO) which raised $100 million, Agenus Inc (NASDAQ: AGEN) which raised $52 million and Idera Pharmaceuticals Inc (NASDAQ: IDRA) which raised $36 million. FierceBiotech.com noted that the�steady flow of about $4.5 billion a year in venture cash�along with�more than $3.5 billion from IPOs last year plus all of the�follow-ons are helping to foster both company growth and�accelerate drug�development programs. Mixed Bag for Biotech IPOs. Last Wednesday also saw two small cap biotech IPOs fizzle in one day�with small cap T cell vaccine developer�Genocea Biosciences Inc (NASDAQ: GNCA) raising $60 million but then ending the day down 8.3% to close at $11 while Dutch drug developer uniQure NV (QURE) raised $81.9 million but fell more than 14% to $14.61. However, orphan drug stock Auspex Pharmaceuticals Inc (NASDAQ: ASPX), which is developing�drugs to treat orphan diseases like Tourette syndrome, saw a 30.5% gain to close at $15.66 and raise $84 million. The Boston Globe quoted Michael Ringel, a partner and managing director at Boston Consulting Group who focuses on health care business, as saying:

  ��he mood is incredibly positive. Capital is flowing. [The biotech IPOs]��have been burning hot. I think it�� too early to suggest that is changing. I can�� predict the overall economy any better than anyone else, but I would expect a pretty good year for IPOs.��/p>

• [By Maxx Chatsko]

  The treatment will add to its quickly growing expertise in blood treatments and biologics. Speaking of which, Baxter and Halozyme (NASDAQ: HALO  ) had HyQvia approved for marketing in Europe�earlier this year. The therapy boosts the immune systems of patients with primary and secondary immunodeficiencies, and combines multiple therapies -- both intravenous and subcutaneous -- into one subcutaneous product. It also allows patients to administer treatment at home every three to four weeks. In other words, it knocks the convenience category out of the park. Halozyme has had a tumultuous life on the public market, so this could be just the stabilizer shareholders need.

• [By Keith Speights]

  Halozyme Therapeutics (NASDAQ: HALO  ) isn't quite as close to commercialization. The company has a mid-stage study under way that combines its rHuPH20 hyaluronidase enzyme with a mealtime insulin analog. Halozyme's enzyme helps the insulin to be absorbed more quickly than it would normally.

• [By Sean Williams]

  The EMA's Committee for Medicinal Products for Human Use, or CHMP, also played a big role in Halozyme Therapeutics' (NASDAQ: HALO  ) huge Friday surge. The EMA's panel recommended Roche's Herceptin SC, which uses Halozyme's recombinant human hyaluronidase in a subcutaneous injection for patients with HER2-positive breast cancer. A typical infusion of Herceptin can take 30 to 90 minutes, whereas the subcutaneous injection can be delivered in a fraction of the time, two to five minutes. This new delivery method could save hospitalization time and money and improve patient comfort. It could also be a transformative approval for Halozyme.�

Hot Heal Care Companies To Invest In 2015: SBA Communications Corporation(SBAC)

SBA Communications Corporation owns and operates wireless communications towers primarily in the United States, Canada, Costa Rica, El Salvador, Guatemala, Nicaragua, and Panama. The company leases antenna space primarily to wireless service providers on towers and other structures that it owns, manages, or leases from others. As of December 31, 2011, it owned 10,524 tower sites. The company also manages or leases approximately 4,800 actual or potential communications sites. In addition, it provides various site development consulting services comprising network pre-design, site audits, identification of potential locations for towers and antennas, support in buying or leasing of the location, and assistance in obtaining zoning approvals and permits, as well as engages in assisting wireless service providers in developing and maintaining wireless service networks. Further, the company offers various site development construction services, including tower and related site c onstruction; antenna installation; and radio equipment installation, commissioning, and maintenance. SBA Communications Corporation was founded in 1989 and is headquartered in Boca Raton, Florida.

Advisors' Opinion:

• [By Jon C. Ogg]

  We just gave a fresh synopsis of which telecom and wireless players could still be up for M&A in the final round of consolidation. American Tower’s market cap is about $28 billion and shares are up more than 4.5% at $71.75. To show how hard things have been, the 52-week trading range is $67.89 to $85.26. What today’s transaction does is quite simply add value to the rest of the public companies that own and operate cell towers:

  Crown Castle International Corp. (NYSE: CCI) is up almost 2.5% at $70.90, against a 52-week range of $63.16 to $81.16. SBA Communications Corp. (NASDAQ: SBAC) is up about 1.8% at $76.70. against a 52-week range of $59.00 to $82.31.

  American Tower expects that the portfolio addition will generate about $345 million in revenues and approximately $270 million of gross margin in 2014. If you value the deal solely on the 5,400 or so owned U.S. towers, this comes up to about $611,000 per tower before calculating the debt and other rights. Suddenly, SBA Communications Corp. (NASDAQ: SBAC) is vindicated because a deal it made in 2012 was deemed pricey as it paid about $1.45 billion for 3,252 towers from TowerCo, at about $445,000 per tower. Crown Castle also has spent close to $2.4 billion to acquire T-Mobile cell tower rights in late 2012.

Hot Heal Care Companies To Invest In 2015: PulteGroup Inc.(PHM)

PulteGroup, Inc., through its subsidiaries, engages in homebuilding and financial services businesses primarily in the United States. The company?s homebuilding business includes the acquisition and development of land primarily for residential purposes within the United States; and the construction of housing on such lands. It offers various home designs, including single-family detached, townhouses, condominiums, and duplexes under the Pulte Homes, Del Webb, and Centex brand names. As of December 31, 2011, its homebuilding operations offered homes for sale in approximately 700 communities. The company?s financial services business consists of mortgage banking and title operations. It arranges financing through the origination of mortgage loans for its homebuyers; sells such loans and related servicing rights; and provides title insurance policies as an agent, and examination and closing services to its home buyers. The company was formerly known as Pulte Homes, Inc. an d changed its name to PulteGroup, Inc. in March 2010. PulteGroup, Inc. was founded in 1956 and is headquartered in Bloomfield Hills, Michigan.

Advisors' Opinion:

• [By Amanda Alix]

  The housing sector's slow recovery appears to be gaining ground, and homebuilders like PulteGroup (NYSE: PHM  ) Ryland Group (NYSE: RY  ) recently reported gains�in first-quarter revenues and substantial increases in sales prices due to rising demand. The U.S. Census Bureau�reported that housing starts for March were well over one million, nearly 47% over that for the same time last year.

Hot Heal Care Companies To Invest In 2015: Berry Plastics Group Inc (BERY)

Berry Plastics Group, Inc. (Berry), incorporated on November 18, 2005, is a provider of plastic consumer packaging and engineered materials. Berry owns 100% interest of Berry Plastics Corporation. Berry sells its solutions predominantly into end markets, such as food and beverage, healthcare and personal care. The Company operates in three segments: Rigid Packaging, Engineered Materials and Flexible Packaging. As of September 19, 2012, the Company supplied its customers through 82 manufacturing facilities throughout the United States (68 locations) and select international locations (14 locations). In June 2012, the Company acquired 100% interest of Frans Nooren Beheer B.V. and its operating companies (Stopaq). In September 2011, the Company acquired 100% interests of Rexam Closures Kentucky Inc., Rexam Delta Inc., Rexam Closures LLC, Rexam Closure Systems LLC, Rexam de Mexico S. de R.L. de C.V., Rexam Singapore PTE Ltd., Rexam Participacoes Ltda. and Rexam Plasticos do Brasil Ltda. (collectively, Rexam SBC). In August 2011, Berry acquired 100% interest of LINPAC Packaging Filmco, Inc.

Rigid Packaging

The Company�� Rigid Packaging business consists of containers, foodservice items, house wares, closures, over caps, bottles, prescription vials, and tubes. The end uses for these products are consumer-oriented end markets, such as food and beverage, retail mass marketers, healthcare, personal care and household chemical. The Company manufactures a collection of container products. The Company produces 32 ounce or thermoformed polypropylene (PP) drink cups and offers a product line with sizes ranging from 12 to 52 ounces. The Company�� products of house wares market is focused on producing semi-disposable plastic home and party and plastic garden products. The Company produces closures and over caps across several of its product lines, including continuous-thread and child-resistant closures, as well as aerosol over caps. The Company also provides a range of custom closure ! solutions including fitments and plugs for medical applications, cups and spouts for liquid laundry detergent, and dropper bulb assemblies for medical and personal care applications.

The Company competes with Airlite, Letica, Polytainers, Silgan, Aptar Group and Reynolds.

Engineered Materials

Berry�� Engineered Materials business primarily consists of pipeline corrosion protection solutions, specialty tapes and adhesives, polyethylene-based film products, and can liners served to a variety of end markets including oil, water and gas infrastructure, industrial and consumer-oriented end markets. The Company produces anti-corrosion products to infrastructure, rehabilitation and pipeline projects throughout the world. Products include heat-shrinkable coatings, single- and multi-layer sleeves, pipeline coating tapes, anode systems for cathodic protection and epoxy coatings. These products are used in oil, gas and water supply and construction applications.

Berry is the manufacturer of cloth and foil tape products. Other tape products include range of splicing and laminating tapes, flame-retardant tapes, vinyl-coated and carton sealing tapes, electrical, double-faced cloth, masking, mounting, original equipment manufacturer (OEM) medical and specialty tapes. These products are sold under the National, Nashua and Polyken brands in the United States. The Company manufactures and sells a portfolio of PE-based film products to end users in the retail markets. These products are sold under brands, such as Ruffies and Film-Gard. Its products include drop cloths and retail trash bags. The Company manufactures customized PP-based, woven and sewn containers for the transportation and storage of raw materials, such as seeds, titanium dioxide, clay and resin pellets.

The Company offers range of polyvinyl chloride (PVC) meat film and agricultural film. Berry�� products are used primarily to wrap fresh meats, poultry and produce for supermarket applic! ations. I! n addition, the Company offers a line of boxed products for food service and retail sales. Berry sells trash-can liners and food bags for offices, restaurants, schools, hospitals, hotels, municipalities and manufacturing facilities. The Company also sells products under the Big City, Hospi-Tuff, Plas-Tuff, Rhino-X and Steel-Flex brands. The Company produces both hand and machine-wrap stretch films, which are used by end users to wrap products and packages for storage and shipping. It sells stretch film products to distributors and retail and industrial end users under the MaxTech and PalleTech brands.

The Company competes with AEP, Sigma and 3M.

Flexible Packaging

The Company�� Flexible Packaging business consists of barrier, multilayer film products, as well as finished flexible packages, such as printed bags and pouches. Berry manufactures and sells a range of film products ranging from mono layer to coextruded films having up to nine layers, lamination films sold primarily to flexible packaging converters and used for peelable lid stock, stand-up pouches, pillow pouches and other flexible packaging formats. The Company also manufactures barrier films used for cereal, cookie, cracker and dry mix packages that are sold directly to food manufacturers like Kraft and Pepsico. It also manufactures films for industrial applications ranging from lamination film for carpet padding to films used in solar panel construction.

The Company supplies component and packaging films used for personal care applications. Berry is a converter of printed bags, pouches and roll stock. Its manufacturing base includes integrated extrusion that combines with printing, laminating, bagmaking, Innolok and laser-score converting processes. The Company is a supplier of printed film products for the fresh bakery, tortilla and frozen vegetable markets with brands, such as SteamQuick Film, Freshview bags and Billboard. The Company manufactures specialty coated and laminated produ! cts for a! range of packaging applications. Its products are sold under the MarvelGuard and MarvelSeal brands and are sold to converters who transform them into finished goods.

The Company competes with Printpak, Tredegar and Bemis.

Advisors' Opinion:

• [By John Udovich]

  One of the most famous scenes in the cult classic, the Graduate, was when Mr. McGuire�took Dustin Hoffman�� character aside and said�"Ben, I want to say one word to you, just one word: Plastics"; but what about the Berry Plastics Group Inc (NYSE: BERY) and its performance verses that of the�iShares S&P 500 Index ETF (NYSEARCA: IVV), iShares Russell Midcap Index Fund ETF (NYSEARCA: IWR) and iShares S&P SmallCap 600 Index ETF (NYSEARCA: IJR)? I should mention that plastics and the Berry Plastics Group was not the place to be yesterday as the stock took a tumble on reduced guidance.